Land: Canada
Språk: engelsk
Kilde: Health Canada
FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE)
JAMP PHARMA CORPORATION
J01XX01
FOSFOMYCIN
3G
POWDER FOR SOLUTION
FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE) 3G
ORAL
8G
Prescription
URINARY ANTI-INFECTIVES
Active ingredient group (AIG) number: 0137036002; AHFS:
APPROVED
2018-03-12
PRODUCT MONOGRAPH PR JAMP-FOSFOMYCIN (MANUFACTURER’S STANDARD) Fosfomycin powder, 3g/sachet (as fosfomycin tromethamine) Antibiotic Jamp Pharma Corporation Date of Revision: March 08, 2018 1310 rue Nobel Boucherville, Québec Canada, J4B 5H3 Submission Control No: 201190 _JAMP-FOSFOMYCIN Product Monograph_ _Page 2 of 25_ P r JAMP-FOSFOMYCIN fosfomycin powder, 3g/sachet (as fosfomycin tromethamine) Antibiotic ACTION AND CLINICAL PHARMACOLOGY JAMP-FOSFOMYCIN (fosfomycin tromethamine), a phosphoric acid derivative is the mono-acid salt of fosfomycin with tromethamine. Fosfomycin is bactericidal in urine at therapeutic doses. Its bactericidal action is due to inactivation of the enzyme enolpyruvyl transferase, thereby blocking the condensation of uridine diphosphate-N- acetylglucosamine with p-enolpyruvate, one of the first steps in bacterial cell synthesis. It also reduces adherence of bacteria to uroepithelial cells. Following oral administration, fosfomycin tromethamine is converted to the free acid, fosfomycin, which is rapidly absorbed. After a single dose of fosfomycin tromethamine(equivalent to 3 g fosfomycin), the mean maximum serum concentration (C max ) achieved within 2 hours is 26.1 mcg/mL in fasted subjects. Absolute oral bioavailability of fosfomycin under fasting conditions is 37% and 30% under fed conditions. When fosfomycin tromethamine is given with a high fat meal, the mean C max achieved is 17.6 mcg/mL within 4 hours. The mean half-life for elimination (t ½ ) in serum is 5.7 hours without food and 5.8 hours with food. Fosfomycin is widely distributed in body tissues and is not bound to plasma proteins. Following a 50 mg/kg dose of fosfomycin, a concentration of 18 mcg/gram in bladder tissue is achieved at 3 hours after dosing. Fosfomycin has been shown to cross the human placental barrier. Fosfomycin tromethamine is not metabolized and is excreted unchanged in urine and feces. Following oral administration of fosfomycin tromethamine to fasted patients, the total body clearance (CL BT ) and mean Les hele dokumentet